http://www.physorg.com/ en-us Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine. Extending hepatitis C treatment for liver transplant patients beyond current practice results in high rates of clearance of the hepatitis C virus from the blood, as well as a low rate of relapse, according to a Henry Ford Hospital study. http://www.physorg.com/news176306924.html Medicine & Health Sun, 01 Nov 2009 14:09:08 EST news176306924 A recent study by researchers from the University of Colorado looked at post-transplant care to determine whether primary care physicians (PCPs) or hepatologists are better suited to manage the overall health care of patients who received a liver transplant (LT). Researchers learned that hepatologists believe metabolic complications to be common in LT patients, but not well controlled. The hepatologists surveyed also felt that PCPs should be responsible for managing these conditions, but that this group was not taking an active role. Full details of this study appear in the October issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases. http://www.physorg.com/news173966341.html Medicine & Health Mon, 05 Oct 2009 13:20:01 EST news173966341 One of the most common reasons for needing a liver transplant is liver failure or liver cancer caused by liver cell infection with hepatitis C virus (HCV). However, in nearly all patients the new liver becomes infected with HCV almost immediately. But now, Hideki Ohdan, Kazuaki Chayama, and colleagues, at Hiroshima University, Japan, have developed an approach that transiently keeps HCV levels down in most treated HCV-infected patients receiving a new liver. http://www.physorg.com/news173640457.html Medicine & Health Thu, 01 Oct 2009 22:00:01 EST news173640457 (AP) -- Apple Inc. CEO Steve Jobs returned Wednesday to the showman role that has helped define his company leadership, taking the stage for the first time since his medical leave to announce such new products as an iPod Nano that records video. http://www.physorg.com/news171724800.html Technology Wed, 09 Sep 2009 14:20:27 EST news171724800 Researchers at the University of North Carolina at Chapel Hill have discovered a genetic risk factor for severe liver disease in people with cystic fibrosis. Those who carry a particular variant of the SERPINA1 gene (also known as alpha-1-antitrypsin or alpha-1-antiprotease) are five times more likely to develop cirrhosis and other liver complications than patients who carry the normal version of the gene. http://www.physorg.com/news171649546.html Medicine & Health Tue, 08 Sep 2009 17:40:02 EST news171649546 Building upon a series of successful preclinical studies, researchers at MassBiologics of the University of Massachusetts Medical School (UMMS) today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody they developed that can neutralize the Hepatitis C virus (HCV). http://www.physorg.com/news168778307.html Medicine & Health Thu, 06 Aug 2009 11:52:16 EST news168778307 Deterioration of renal function with CNI therapy has been widely reported in liver transplant recipients. Microproteinuria has been used to monitor the early changes of nephropathy in renal disease or cardiovascular events. However, whether microproteinuria could be used as an early and sensitive indicator to monitor CNI-related nephrotoxicity in liver transplant recipients has not been unequivocally addressed. http://www.physorg.com/news165488685.html Medicine & Health Mon, 29 Jun 2009 11:10:02 EST news165488685 (AP) -- Apple co-founder and CEO Steve Jobs has an "excellent prognosis" after receiving a liver transplant at a Tennessee hospital, a doctor confirmed Tuesday. http://www.physorg.com/news165038077.html Technology Wed, 24 Jun 2009 04:55:09 EST news165038077 (AP) -- This week, Apple Inc. wasn't shy about touting the sales of its latest mobile device. But the company didn't say anything confirming reports from over the weekend that co-founder and CEO Steve Jobs had a liver transplant two months ago. http://www.physorg.com/news164909370.html Technology Mon, 22 Jun 2009 17:10:09 EST news164909370 (AP) -- Five and a half months ago, word that Steve Jobs would only work part-time as he recovered from a liver transplant would have sent investors into a selling frenzy, so closely linked was Apple's charismatic co-founder and CEO to the company's success. http://www.physorg.com/news164866216.html Technology Mon, 22 Jun 2009 05:10:37 EST news164866216 The first artificial organ for liver patients that uses immortalized human liver cells, the Extracorporeal Liver Assist Device, or ELAD(R), is a bedside system that treats blood plasma, metabolizing toxins and synthesizing proteins just like a real liver does. http://www.physorg.com/news163163349.html Medicine & Health Tue, 02 Jun 2009 12:11:49 EST news163163349 Two new studies address donor factors that could affect outcomes for liver transplant recipients, particularly those with chronic hepatitis C (HCV). One found that donor steatosis, or fat in the liver, does not affect liver disease progression or three-year survival in recipients with or without HCV. However, transplants from people higher on the Donor Risk Index did adversely affect the outcomes of HCV-positive recipients more than recipients without HCV. http://www.physorg.com/news162740009.html Medicine & Health Thu, 28 May 2009 14:33:52 EST news162740009 Researchers have discovered a novel molecular path that predisposes patients to develop primary biliary cirrhosis, a disease that mainly affects women and slowly destroys their livers. Primary biliary cirrhosis has no known cause. http://www.physorg.com/news162664294.html Medicine & Health Wed, 27 May 2009 17:31:58 EST news162664294 A 58-year-old Singaporean pastor is recovering well after undergoing Asia's first simultaneous heart and liver transplant, his medical team said Friday. http://www.physorg.com/news159778452.html Medicine & Health Fri, 24 Apr 2009 07:54:53 EST news159778452 It started as something of a medical mystery that, at first, doctors couldn't figure out. http://www.physorg.com/news158941890.html Medicine & Health Tue, 14 Apr 2009 15:32:55 EST news158941890 Blocking off the splenic artery, either through surgical ligation or radiological coiling, helped six out of seven patients suffering from small-for-size syndrome after a partial liver transplant. This finding is in the February issue of Liver Transplantation. http://www.physorg.com/news152902116.html Medicine & Health Tue, 03 Feb 2009 16:49:00 EST news152902116 A new Canadian study comparing cancer rates of liver transplant patients to those of the general population has found that transplant recipients face increased risks of developing cancer, especially non-Hodgkin's lymphoma and colorectal cancer. Risks were more pronounced during the first year of follow-up and among younger transplant recipients. These findings are published in the November issue of Liver Transplantation, a journal by John Wiley & Sons. http://www.physorg.com/news144946240.html Medicine & Health Mon, 03 Nov 2008 14:50:40 EST news144946240 The pain is debilitating. The only option: smoking medical marijuana. That's the reality for many hepatitis C patients whose road to health includes a liver transplant. Although Canadian transplant centres are more willing than those in the United States, not everyone says yes to liver patients who smoke marijuana, and a University of Alberta researcher says that decision-making process is unacceptable. http://www.physorg.com/news143913664.html Medicine & Health Wed, 22 Oct 2008 17:01:04 EST news143913664 Cancer incidence is higher among liver transplant recipients in Finland compared to the general population, according to a new study in the October issue of Liver Transplantation. http://www.physorg.com/news142166426.html Medicine & Health Thu, 02 Oct 2008 11:40:26 EST news142166426